Biocartis Group NV (BCART) - Total Liabilities

Latest as of June 2023: €166.97 Million EUR ≈ $195.20 Million USD

Based on the latest financial reports, Biocartis Group NV (BCART) has total liabilities worth €166.97 Million EUR (≈ $195.20 Million USD) as of June 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Biocartis Group NV cash flow conversion to assess how effectively this company generates cash.

Biocartis Group NV - Total Liabilities Trend (2012–2022)

This chart illustrates how Biocartis Group NV's total liabilities have evolved over time, based on quarterly financial data. Check Biocartis Group NV liquidity resilience to evaluate the company's liquid asset resilience ratio.

Biocartis Group NV Competitors by Total Liabilities

The table below lists competitors of Biocartis Group NV ranked by their total liabilities.

Company	Country	Total Liabilities
GeneMatrix Inc KQ:109820	Korea	₩9.72 Billion
Shivam Autotech Limited NSE:SHIVAMAUTO	India	Rs4.75 Billion
WI Co. Ltd. KQ:073570	Korea	₩2.15 Billion
Mount Ridley Mines Ltd AU:MRD	Australia	AU$52.21K
PNC Technologies co. Ltd KQ:237750	Korea	₩21.30 Billion
Siili Solutions Oyj HE:SIILI	Finland	€38.04 Million
4C Group AB ST:4C	Sweden	Skr248.63 Million
IL&FS Investment Managers Limited NSE:IVC	India	Rs147.85 Million

Liability Composition Analysis (2012–2022)

This chart breaks down Biocartis Group NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BCART stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.15	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-3.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.48	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biocartis Group NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biocartis Group NV (2012–2022)

The table below shows the annual total liabilities of Biocartis Group NV from 2012 to 2022.

Year	Total Liabilities	Change
2022-12-31	€144.56 Million ≈ $169.01 Million	-18.04%
2021-12-31	€176.38 Million ≈ $206.20 Million	+1.55%
2020-12-31	€173.69 Million ≈ $203.07 Million	-5.52%
2019-12-31	€183.84 Million ≈ $214.93 Million	+253.32%
2018-12-31	€52.03 Million ≈ $60.83 Million	+6.30%
2017-12-31	€48.95 Million ≈ $57.23 Million	+10.21%
2016-12-31	€44.42 Million ≈ $51.93 Million	+32.74%
2015-12-31	€33.46 Million ≈ $39.12 Million	+2.23%
2014-12-31	€32.73 Million ≈ $38.27 Million	+16.11%
2013-12-31	€28.19 Million ≈ $32.96 Million	-4.08%
2012-12-31	€29.39 Million ≈ $34.36 Million	--

About Biocartis Group NV

BR:BCART Belgium Diagnostics & Research

Market Cap

$31.84 Million

€27.24 Million EUR

Market Cap Rank

#24031 Global

#97 in Belgium

Share Price

€0.29

Change (1 day)

+0.00%

52-Week Range

€0.29 - €0.29

All Time High

€12.88